Summary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
Summary The U.S. Centers for Medicare & Medicaid Services (CMS) just completed the open comment period for their draft national coverage decision…
Summary – In mid-January, the Centers for Medicare & Medicaid Services (CMS) issued a draft national coverage decision for Biogen’s Alzheimer’s drug…
Summary : A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity…
Summary : First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children with early-onset MLD recently treated…
Synopsis: The EMA’s human medicines committee has said it cannot approve Biogen and Eisai’s Alzheimer’s disease therapy Aduhelm, saying it was unconvinced…
Summary- BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Backed by EU…
DIMPROPYRIDAZ NEW INSECTICIDE FROM BASF SUBMITTED FOR REGULATORY REGISTRATION Axalion (Dimpropyridaz) is pyrazole carboxamide class of insecticides. Dimpropyridaz chemically is a pyrazole…